Baronsmead Second Venture Trust (LON:BMD) Hits New 52-Week Low – Time to Sell?

Baronsmead Second Venture Trust (LON:BMD)’s share price reached a new 52-week low during trading on Tuesday . The company traded as low as GBX 50 ($0.65) and last traded at GBX 50 ($0.65), with a volume of 16370 shares. The stock had previously closed at GBX 51 ($0.66).

Baronsmead Second Venture Trust Price Performance

The stock has a market capitalization of £195.84 million, a price-to-earnings ratio of 43.24 and a beta of 0.24. The firm has a 50-day moving average of GBX 51.72 and a 200 day moving average of GBX 53.81.

Baronsmead Second Venture Trust (LON:BMD) last posted its quarterly earnings data on Tuesday, December 24th. The company reported GBX 0.48 ($0.01) EPS for the quarter. Baronsmead Second Venture Trust had a return on equity of 1.95% and a net margin of 38.32%.

Baronsmead Second Venture Trust Increases Dividend

The firm also recently declared a dividend, which was paid on Monday, March 17th. Shareholders of record on Thursday, February 13th were issued a dividend of GBX 2.25 ($0.03) per share. This represents a dividend yield of 4.21%. This is a boost from Baronsmead Second Venture Trust’s previous dividend of $1.75. The ex-dividend date was Thursday, February 13th. Baronsmead Second Venture Trust’s dividend payout ratio is presently 345.90%.

Insider Activity

In other news, insider Adriana Stirling bought 18,002 shares of Baronsmead Second Venture Trust stock in a transaction dated Thursday, February 20th. The stock was purchased at an average price of GBX 56 ($0.73) per share, for a total transaction of £10,081.12 ($13,094.06). 0.15% of the stock is currently owned by company insiders.

Baronsmead Second Venture Trust Company Profile

Baronsmead Second Venture Trust plc is a venture capital trust managed by ISIS Equity Partners LLP. It invests in a portfolio of unquoted companies in the United Kingdom. The trust primarily invests in the media, business services, consumer, information technology support services, technology-enabled companies, and healthcare sectors.